[Diabetes-talk] Fw: Thru Our Eyes interviews, Wed. May 19, diabetes, tech tips, book reviews, etc

[Vincent Chaney]

Thru Our Eyes announces a doubleheader of education, information and 
inspiration!

On Wednesday, May 19, at 8:00 EDT, Joe Ruffalo, member of the NFB 
board of directors and affiliate president in New Jersey,  will host 
an hour interview with a timely topic on diabetes.
Joe and his guests, Jerry Munden, vice president of business 
development for Prodigy Diabetes Care and Jordan Benis, chief 
operations officer for Advanced Diabetic Solutions will discuss the following:
The history of each of the companies
Their company's blood glucose monitors, the Prodigy Voice and the Solo V2
The importance of blood glucose monitoring by all diabetics
Medicare and private insurance coverage for the audible blood glucose 
monitors and the difficulties experienced by many
Jerry Munden will discuss the Prodigy Count-a-Dose and other products 
by Prodigy Diabetes Care available now and to come.
Jordan Benis will speak about ADS and the other diabetic products 
they have, I.e. socks, shoes, slippers, etc.
The objective for this very educational and informative interview is 
to provide the diabetic audience the knowledge of audible, accessible 
tools and information in their choice of a monitor and other diabetic products.
  Immediately following, The Bright Side will conduct an informative 
interview hosted by Jane Degenshein, a member of the at large chapter 
of the NFBNJ and leader of Eyes Closed, Hearts Open, ECHO and Jerry 
Moreno, president of a local chapter in North Carolina and a long 
time member of the NFB who will interview, Rebecca Irvin, member of 
the NFBNJ, northern chapter, Braille tutor, active member in her 
community and a true leader.
Also highlighted will be Jerry's tech tips and Jane's book reviews.

How to access Thru Our Eyes:
Logging into <http://www.thruoureyes.org>www.thruoureyes.org
or for JAWS users, 
<http://www.thruoureyes.org/jaws.html>www.thruoureyes.org/jaws.html
If you wish to call in a question or comment, please dial 1 888 572 0141